Zhong Seminar - February
Join us on Thursday, February 12, from 12:00 - 1:00 p.m., in Auditorium A at University Hospital, as Dr. Douglas D. Fraser, discusses “Long COVID (LC)-Revitalize: A Precision Medicine Driven Phase III Double-Blinded, Placebo Controlled, Multi-Arm Platform Clinical Drug Trial.”
Date: Thursday, February 12, 2026
Time: 12:00 – 1:00 p.m.
Location: Auditorium A, University Hospital
Zoom: Click here
Learning objectives:
-
Understand how artificial intelligence-guided proteomic analysis identified biological pathways and informed selection of repurposed treatment candidates.
-
Describe the adaptive platform trial design that allows for real-time adjustments based on interim results, including potential drug combinations, discontinuation of ineffective arms, or expansion of successful interventions across global populations.
-
Explain how precision medicine approaches can target symptom domains through patient-specific outcome measures to address disease heterogeneity across diverse international populations.
